Pfizer will dominate $28 billion COVID-pill market in 2022
MELBOURNE: Pfizer is set to dominate a $US20 billion ($27.9 billion) market for ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
